Nevro Corp [NVRO] stock is trading at $5.73, up 0.17%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVRO shares have gain 0.17% over the last week, with a monthly amount glided 11.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Nevro Corp [NYSE: NVRO] stock has seen the most recent analyst activity on February 10, 2025, when Jefferies upgraded its rating to a Hold and also boosted its price target to $5.85 from $4.50. Previously, Piper Sandler upgraded its rating to Overweight on February 07, 2025, and dropped its price target to $5.85. On December 03, 2024, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $5 on the stock. Morgan Stanley downgraded its rating to a Underweight and decreased its price target to $4 on December 02, 2024. Citigroup upgraded its rating to a Neutral. Wolfe Research upgraded its rating to Peer Perform for this stock on August 08, 2024. In a note dated August 07, 2024, Wells Fargo downgraded an Underweight rating on this stock and revised its target price from $13 to $5.50.
Nevro Corp [NVRO] stock has fluctuated between $3.16 and $16.12 over the past year. Currently, Wall Street analysts expect the stock to reach $4.5 within the next 12 months. Nevro Corp [NYSE: NVRO] shares were valued at $5.73 at the most recent close of the market. An investor can expect a potential drop of -21.47% based on the average NVRO price forecast.
Analyzing the NVRO fundamentals
Nevro Corp [NYSE:NVRO] reported sales of 419.15M for the trailing twelve months, which represents a drop of -6.69%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.18%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.25 and Total Capital is -0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.9.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.72 points at the first support level, and at 5.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.74, and for the 2nd resistance point, it is at 5.75.
Ratios To Look Out For
For context, Nevro Corp’s Current Ratio is 5.02. Also, the Quick Ratio is 3.76, while the Cash Ratio stands at 0.75. Considering the valuation of this stock, the price to sales ratio is 0.52, the price to book ratio is 0.78.
